课题基金 / 基金详情

项目摘要

项目成果

Gary Allen Wayman的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):重度抑郁症(MDD)是一种复发性精神疾病,大约六分之一的美国人在其一生中至少遭受一次折磨。虽然病因可能是多因素的,但MDD的发病与海马的结构缺陷有关,包括树突形态的改变。神经营养因子的水平,如刺激树突生长的脑源性神经营养因子(BDNF),在患有重度抑郁症的人和患有重度抑郁症的动物模型中都有所下降。然而,虽然已知BDNF水平的下降与树突形态的改变有关,但BDNF刺激树突生长的潜在信号机制尚不清楚。识别这些通路对于理解树突发育和突触发生如何正常发生以及在MDD发作期间如何发生改变至关重要。我们的长期目标是识别神经营养因子控制树突发育的细胞内信号,并确定这些信号在正常和抑郁大脑中是如何被调节的。本应用程序的目的是确定一个关键的神经营养因子BDNF控制树突形态发生、突触发生和突触结构维持的信号通路。我们的中心假设是BDNF通过一种协调的反应来刺激树突的发育,这种反应包括对关键蛋白质编码基因和非编码microrna的基因组调控,后者的表达在抑郁症期间发生改变。我们根据已发表和未发表的数据提出了这一假设,这些数据表明,CREB依赖性蛋白编码基因和非编码microrna的增加对BDNF依赖性树突生长和突触发生至关重要。这些事件的结合不仅激活了促进树突生长的途径,而且抑制了抑制树突生长的途径。我们将用以下具体目标来检验我们的中心假设:确定CREB调节的蛋白编码基因在bdnf刺激的树突生长和突触发生中的需求。2. 确定在BDNF依赖性树突生长和突触发生中对CREB调控的微rna的需求。确定蛋白质编码基因和微rna在体内正常发育和BDNF表达改变期间的作用。我们将使用生化、遗传、细胞生物学、行为和成像方法来解决这些具体目标。这项研究的基本原理是,一旦了解了连接BDNF与树突和脊柱重塑的关键信号分子,它们就可以成为治疗和预防重度抑郁症的目标。这些研究具有创新性,因为它们将PI在信号转导方面的专业知识应用于一个关键的、尚待研究的问题:确定抑郁症期间发生的结构变化的分子机制。我们得到了我们的顾问Jaak Panksepp的帮助,他在研究抑郁症模型方面有丰富的经验。此外,这些结果预计将对该领域产生广泛的影响,因为树突树突和脊髓发生异常在许多形式的智力迟钝中都很常见,包括脆性X染色体、唐氏综合症和Rett综合征。
英文摘要
DESCRIPTION (PROVIDED BY APPLICANT): Major Depressive Disorder (MDD) is a recurrent mental illness that afflicts approximately 1 in 6 Americans at least once during their lifetime. While the causes are likely to be multi-factoral, the onset of MDD correlates with structural defects in the hippocampus, including alterations in dendritic morphology. The levels of neurotrophic factors like Brain Derived Neurotrophic Factor (BDNF), which stimulates dendritic growth, are decreased in both humans suffering from MDD and in animal models of MDD. However, while the decrease in BDNF levels is known to correlate with alterations in dendritic morphology, the underlying signaling mechanisms by which BDNF stimulates dendritic growth are unknown. Identifying these pathways is critical to understand how dendritic development and synaptogenesis occurs normally and how it is altered during bouts of MDD. Our long-range goal is to identify the intracellular signals by which neurotrophic factors control dendritic development and to determine how these signals are regulated in both normal and depressed brains. The objective of this application is to determine the signaling pathways by which one critical neurotrophic factor, BDNF, controls dendritic morphogenesis, synaptogenesis and the maintenance of synaptic structures. Our central hypothesis is that BDNF stimulates dendritic development via a coordinated response comprised of genomic regulation of both critical protein-coding genes and non-coding microRNAs whose expression are altered during depression. We have formulated this hypothesis on the basis of our published and unpublished data, which shows that an increase CREB dependent regulation of both protein coding genes and non-coding microRNAs are essential for BDNF dependent dendritic growth and synaptogenesis. The combination of these events not only activates pathways that promote dendritic growth but also inhibits pathways that suppress dendritic growth. We will test our central hypothesis with the following Specific Aims: 1. Determine the requirement of CREB regulated protein coding genes in BDNF-stimulated dendritic growth and synaptogenesis. 2. Determine the requirement for CREB regulated micro-RNAs in BDNF dependent dendritic growth and synaptogenesis. Determine the role of protein coding genes and micro-RNAs in vivo during normal development and during periods of altered BDNF expression. We will use biochemical, genetic, cell biological, behavioral and imaging approaches to address these specific aims. The rationale that underlies the proposed research is that once the critical signaling molecules linking BDNF to dendritic and spine remodeling become known they can be targeted for the treatment and prevention of MDD. These studies are innovative because they apply the expertise of the PI in signal transduction to a critical and under examined problem: to identify the molecular mechanisms underlying structural changes occurring during depression. We have enlisted the help of our consultant Jaak Panksepp, who has extensive experience in studying models of depression. Additionally, these results are expected to have a broad impact on the field as abnormalities in dendritic arborization and spinogenesis are common to numerous forms of mental retardation including Fragile X, Down's, and Rett syndromes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leptin regulation of GABAergic synaptogenesis and excitation-inhibition balance during development: effects of maternal obesity
  • 批准号:
    10197984
  • 项目类别:
  • 资助金额:
    $39.87万
  • 财政年份:
    2018
  • 负责人:
    Gary Allen Wayman
  • 依托单位:
Leptin regulation of GABAergic synaptogenesis and excitation-inhibition balance during development: effects of maternal obesity
  • 批准号:
    10436314
  • 项目类别:
  • 资助金额:
    $39.87万
  • 财政年份:
    2018
  • 负责人:
    Gary Allen Wayman
  • 依托单位:
Control of Dendritic and Synaptic Development by Extracellular Cues
  • 批准号:
    8585100
  • 项目类别:
  • 资助金额:
    $37.0万
  • 财政年份:
    2009
  • 负责人:
    Gary Allen Wayman
  • 依托单位:
Control of Dendritic and Synaptic Development by Extracellular Cues
  • 批准号:
    7995503
  • 项目类别:
  • 资助金额:
    $37.0万
  • 财政年份:
    2009
  • 负责人:
    Gary Allen Wayman
  • 依托单位:
海外基金